Abstract
The high cost of drug discovery and development requires more efficient approaches to the identification and inhibition of tractable protein targets. One strategy is to pursue families of proteins that already possess affinity for a drug lead scaffold, where that scaffold plays the dual role of serving (a) when tethered to a resin, as a ligand to purify a subproteome of interest, and (b) as a lead molecule that has the potential for optimization for a given member of the subproteome. Here, we describe an example of the purification of a subproteome using a scaffold tailored to the dehydrogenase family of enzymes. Combined with modern LC-MS/MS methods and subsequent searching of proteome databases, such affinity chromatography strategies can be used to purify and identify any proteins with affinity for the scaffold molecule. The method is exemplified using the CRAA (catechol rhodanine acetic acid) privileged scaffold, which is tailored to dehydrogenases. CRAA affinity column chromatography, combined with LC-MS/MS, is described as a method for profiling dehydrogenase subproteomes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Speers, A. E., and Cravatt, B. F. (2004) Chemical Strategies for Activity-Based Proteomics. Chembiochem. 5, 41–47.
Tate, E. W. (2008) Recent Advances in Chemical Proteomics: Exploring the Post-Translational Proteome. J. Chem. Biol. 1, 17–26.
Kruse, U., Bantscheff, M., Drewes, G., and Hopf, C. (2008) Chemical and Pathway Proteomics: Powerful Tools for Oncology Drug Discovery and Personalized Health Care. Mol. Cell. Proteomics. 7, 1887–1901.
Rix, U., and Superti-Furga, G. (2009) Target Profiling of Small Molecules by Chemical Proteomics. Nat. Chem. Biol. 5, 616–624.
Jeffery, D. A., and Bogyo, M. (2003) Chemical Proteomics and its Application to Drug Discovery. Curr. Opin. Biotechnol. 14, 87–95.
Verhelst, S. H., and Bogyo, M. (2005) Chemical Proteomics Applied to Target Identification and Drug Discovery. BioTechniques. 38, 175–177.
Fonovic, M., and Bogyo, M. (2008) Activity-Based Probes as a Tool for Functional Proteomic Analysis of Proteases. Expert Rev. Proteomics. 5, 721–730.
Sieber, S. A., and Cravatt, B. F. (2006) Analytical Platforms for Activity-Based Protein Profiling--Exploiting the Versatility of Chemistry for Functional Proteomics. Chem. Commun. (Camb). 22, 2311–2319.
Sem, D. S., Bertolaet, B., Baker, B., Chang, E., Costache, A. D., Coutts, S., Dong, Q., Hansen, M., Hong, V., Huang, X., Jack, R. M., Kho, R., Lang, H., Ma, C. T., Meininger, D., Pellecchia, M., Pierre, F., Villar, H., and Yu, L. (2004) Systems-Based Design of Bi-Ligand Inhibitors of Oxidoreductases: Filling the Chemical Proteomic Toolbox. Chem. Biol. 11, 185–194.
Kho, R., Baker, B. L., Newman, J. V., Jack, R. M., Sem, D. S., Villar, H. O., and Hansen, M. R. (2003) A Path from Primary Protein Sequence to Ligand Recognition. Proteins. 50, 589–599.
Kho, R., Newman, J. V., Jack, R. M., Villar, H. O., and Hansen, M. R. (2003) Genome-Wide Profile of Oxidoreductases in Viruses, Prokaryotes, and Eukaryotes. J. Proteome Res. 2, 626–632.
Argyrou, A., Jin, L., Siconilfi-Baez, L., Angeletti, R. H., and Blanchard, J. S. (2006) Proteome-Wide Profiling of Isoniazid Targets in Mycobacterium Tuberculosis. Biochemistry. 45, 13947–13953.
El-Kabbani, O., Ruiz, F., Darmanin, C., and Chung, R. P. (2004) Aldose Reductase Structures: Implications for Mechanism and Inhibition. Cell Mol. Life Sci. 61, 750–762.
Ramirez, M. A., and Borja, N. L. (2008) Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy. Pharmacotherapy. 28, 646–655.
Trayer I.P., and Trayer H.R. (1974) Affinity Chromatography of Nicotinamide Nucleotide-Dependent Dehydrogenases on Immobilized Nucleotide Derivatives. Biochem. J. 141, 775–787.
Ge, X., Olson, A., Cai, S., and Sem, D. S. (2008) Binding Synergy and Cooperativity in Dihydrodipicolinate Reductase: Implications for Mechanism and the Design of Biligand Inhibitors. Biochemistry . 47, 9966–9980.
Ge, X., Wakim, B., and Sem, D. S. (2008) Chemical Proteomics-Based Drug Design: Target and Antitarget Fishing with a Catechol-Rhodanine Privileged Scaffold for NAD(P)(H) Binding Proteins. J. Med. Chem. 51, 4571–4580.
Kim, C. Y., Webster, C., Roberts, J. K., Moon, J. H., Alipio Lyon, E. Z., Kim, H., Yu, M., Hung, L. W., and Terwilliger, T. C. (2009) Analysis of Nucleoside-Binding Proteins by Ligand-Specific Elution from Dye Resin: Application to Mycobacterium Tuberculosis Aldehyde Dehydrogenases. J. Struct. Funct. Genomics.
Singh, R., and Mozzarelli, A. (2009) Cofactor Chemogenomics. Methods Mol. Biol. 575, 93–122.
Katayama, H., and Oda, Y. (2007) Chemical Proteomics for Drug Discovery Based on Compound-Immobilized Affinity Chromatography. J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci. 855, 21–27.
Vanin, E. F., and Ji, T. H. (1981) Synthesis and Application of Cleavable Photoactivable Heterobifunctional Reagents. Biochemistry. 20, 6754–6760.
Witzemann V., Muchmore D., and Raftery M.A. (1979) Affinity-Directed Cross-Linking of Membrane-Bound Acetylcholine Receptor Polypeptides with Photolabile Alpha-Bungarotoxin Derivatives. Biochemistry. 18, 5511–5518.
Morelli A., and Benatti U. (1974) Simple Chemical Synthesis of a Specific Effector for the Affinity Chromatography of Nicotinamide Adenine Dinucleotide Phosphate-Dependent Dehydrogenases. Ital. J. Biochem. 23, 279–291.
Acknowledgments
We thank Dr. Bassam Wakim for assistance with mass spectrometry studies. This work was supported in part by GM085739 (NIH) and shared instrumentation grants S10 RR019012 (NIH) and CHE-0521323 (NSF).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Ge, X., Sem, D.S. (2012). Affinity-Based Profiling of Dehydrogenase Subproteomes. In: Drewes, G., Bantscheff, M. (eds) Chemical Proteomics. Methods in Molecular Biology, vol 803. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-364-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-61779-364-6_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-363-9
Online ISBN: 978-1-61779-364-6
eBook Packages: Springer Protocols